Mustang Bio extends asset sale deadline for Worcester facility to July 31, 2023

MUSTANG BIO, INC.

Mustang Bio and uBriGene amended Asset Purchase Agreement to extend Outside Date from June 30 to July 31, 2023.
Extension provides additional time to obtain landlord approval for site lease transition.
Parties may mutually extend in 30-day increments if only condition is landlord consent.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

MUSTANG BIO, INC. amended Asset Purchase Agreement with uBriGene (Boston) Biosciences, Inc. valued at Extended Outside Date to July 31, 2023 (effective 2023-06-29).

Action: amendment
Agreement: asset purchase
Counterparty: uBriGene (Boston) Biosciences, Inc.
Value: Extended Outside Date to July 31, 2023
Effective: 2023-06-29

Exact text from the filing

On June 29, 2023 the Company and uBriGene entered into an amendment to the Asset Purchase Agreement (the “ Amendment ”), to extend the Outside Date to July 31, 2023.

View on SEC.gov

Browse all material agreements →

MUSTANG BIO, INC. filing history →

Source: SEC EDGAR

accession 0001558370-23-011634

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.